Summary of patient demographics, preprocedural findings, periprocedural findings, and outcomes after 3 months
| Patient Demographics | No. (%) or Median (IQR) | Range |
|---|---|---|
| Age (yr) | 65 (63–76) | 51–84 |
| Male | 31 (88.6) | – |
| Previous medical history | – | – |
| Diabetes mellitus | 7 (20.0) | – |
| Hypertension | 19 (54.3) | – |
| Hypercholesterolemia | 10 (28.6) | – |
| Smoking | 17 (48.6) | – |
| Cardiac disease | 5 (14.3) | – |
| Prior stroke | 6 (17.1) | – |
| Preprocedural findings | ||
| Time to hospital (min)a | 180 (125–210) | 60–340 |
| Time to IA therapy (min)a | 270 (190–310) | 140–435 |
| NIHSS at admission | 12 (8–17) | 6–22 |
| Modified Rankin scale | 4 (3–4) | 3–5 |
| 3 | 11 (31.4) | – |
| 4 | 21 (60.0) | – |
| 5 | 3 (8.6) | – |
| Right-sided occlusion | 15 (42.9) | – |
| Tandem occlusion site | – | – |
| M1 | 25 (71.4) | – |
| M2 | 5 (14.3) | – |
| Distal ICA thrombus | 5 (14.3) | – |
| Received IV rtPA | 8 (22.9) | – |
| Periprocedural findings | ||
| Procedure duration (min) | 90 (68–120) | 40–180 |
| Urokinase dose (× 104 U) | 10 (10–30) | 10–50 |
| TICI grade | – | – |
| IIa | 9 (25.7) | – |
| IIb | 7 (20.0) | – |
| III | 19 (54.3) | – |
| Complications | 2 (5.7) | – |
| Symptomatic hemorrhage | 1 (2.9) | – |
| Brain swelling | 1 (2.9) | – |
| Follow-up evaluation at 3 months | ||
| NIHSSb | 4 (2–7) | 1–17 |
| Modified Rankin Scale | 2 (1–3) | 0–6 |
| 0 | 3 (8.6) | – |
| 1 | 11 (31.4) | – |
| 2 | 8 (22.9) | – |
| 3 | 5 (14.3) | – |
| 4 | 4 (11.4) | – |
| 5 | 0 (0.0) | – |
| 6 | 4 (11.4) | – |
| Favorable outcome | 22 (62.9) | – |
| Mortality | 4 (11.4) | – |